Eradication of Helicobacter pylori in functional dyspepsia: Randomised double blind placebo controlled trial with 12 months' follow up

BMJ

Volumn 318, Issue 7187, 1999, Pages 833-837

  Talley, Nicholas J ^a   Janssens, Jef ^b   Lauritsen, Karsten ^c   Rácz, István ^d   Bolling Sternevald, Elisabeth ^e  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^d Petz Aladar Teaching and County Hospital   (United States)

^e LINKÖPING UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CARBON 13; CLARITHROMYCIN; OMEPRAZOLE; UREA;

ADULT; ARTICLE; AUSTRALIA; BREATH ANALYSIS; CHRONIC GASTRITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; DYSPEPSIA; ERADICATION THERAPY; EUROPE; FEMALE; FOLLOW UP; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEW ZEALAND; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; STOMACH BIOPSY; SYMPTOM;

ADULT; AMOXICILLIN; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; CLARITHROMYCIN; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; DYSPEPSIA; FEMALE; FOLLOW-UP STUDIES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; OMEPRAZOLE; TREATMENT OUTCOME;

EID: 0033608720     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.318.7187.833     Document Type: Article

References (26)

1. Talley NJ, Colin-Jones D, Koch KL, Koch M, Nyrén O, Stanghellini V. Functional dyspepsia. A classification with guidelines for diagnosis and management. Gastroenterol Int 1991; 4: 145–160.
2. Bernersen B, Johnsen R, Bostad L, Straume B, Sommer AI, Burhol PG. Is Helicobacter pylori the cause of dyspepsia? BMJ 1992; 304: 1276–1279.
3. Armstrong D. Helicobacter pylori infection and dyspepsia. Scand J Gastroenterol 1996; 31(suppl 215): 38-47.
4. Bytzer P. Diagnosing dyspepsia any controversies left? Gastroenterology 1996; 110: 302–306.
5. Strauss RM, Wang TC, Kelsey PB, Campton CC, Ferraro MT, Perez-Perez G, et al. Association of Helicobacter pylori infection with dyspeptic symptoms in patients undergoing gastroduodenoscopy. Am J Med 1990; 89: 464–469.
6. Schubert TT, Schubert AB, Ma CK. Symptoms, gastritis, and Helicobacter pylori in patients referred for endoscopy. Gastrointest Endosc 1992; 38: 357–360.
7. Nandurkar S, Talley NJ, Xia H, Mitchell H, Hazell S, Jones M. Dyspepsia in the community is linked to smoking and aspirin use but not to Helicobacter pylori infection. Arch Intern Med 1998; 158: 1427–1433.
8. Talley NJ. A critique of therapeutic trials in Helicobacter pylori positive functional dyspepsia. Gastroenterology 1994; 106: 1174–1183.
9. Veldhuyzen van Zanten SJO, Cleary C, Talley NJ, Peterson TC, Nyren O, Bradley L, et al. Drug treatment of functional dyspepsia: A systematic analysis of trial methodology with recommendations for design of future trials. Am J Gastroenterol 1996; 91: 660–673.
10. Laheij RJF, Jansen JBMJ, Vandelisdonk EH, Verbeek ALM. Symptom improvement through eradication of Helicobacter pylori with non-ulcer dyspepsia. Alimen Pharmacol Ther 1996; 10: 843–850.
11. Talley NJ, Hunt RH. What role does Helicobacter pylori play in non ulcer dyspepsia? Arguments for and against H. pylori being associated with dyspeptic symptoms. Gastroenterology 1997; (suppl 6): 67-77S.
12. McCarthy C, Patchett S, Collins RM, Beattie S, Keane C, O'Morain C. Long term prospective study of Helicobacter pylori in non-ulcer dyspepsia. Dig Dis Sci 1995; 40: 114–119.
13. Gilvarry J, Buckley MJM, Beattie S, Hamilton H, O'Morain CA. Eradication of Helicobacter pylori affects symptoms in non-ulcer dyspepsia. Scand J Gastroenterol 1997; 32: 535–540.
14. Junghard O, Talley NJ, Wiklund I. Validation of seven graded diary cards for severity of dyspeptic symptoms in patients with non-ulcer dyspepsia. Europ J Surg 1998; 583: 106–111.
15. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney system. International workshop in the histology of gastritis, Houston 1994. Am J Surg Pathol 1996; 20: 1161–1181.
16. Dominguez-Munoz JE, Leodolter A, Sauerbruch T, Malfartheiner P. A citric acid solution is an optimal test drink in the 13C-urea breath test for the diagnosis of Helicobacter pylori infection. Gut 1997; 40: 459–462.
17. Revicki DA, Wood M, Wiklund I, Crawley J. Reliability and validity of the gastrointestinal symptom rating scale in patients with gastroesophageal reflux. Qual Life Res 1998; 7: 75–83.
18. Goves J, Oldring JK, Kerr D, Dallara RG, Roffe EJ, Powell JA, et al. First line treatment with omeprazole provides an effective and superior alternative strategy in the management of dyspepsia compared to antacid/alginate liquid: A multicentre study in general practice. Aliment Pharmacol Ther 1998; 12: 147–157.
19. Wiklund I, Bardhan KD, Muller-Lisner S, Bigard MA, Bianchi-Porro G, Ponce J, et al. Quality of life during acute and intermittent treatment of gastroesophageal reflux disease with omeprazole compared with ranitidine. Results from a multicentre study. Ital J Gastroenterol Hepatol 1998; 30: 19–27.
20. Dimenas E, Glise H, Hallerback B, Hernqvist H, Svedlund J, Wiklund I. Well-being and gastrointestinal symptoms among patients referred to endoscopy owing to suspected duodenal ulcer. Scand J Gastroenterol 1995; 30: 1046–1052.
21. Talley NJ, Weaver AL, Zinsmeister AR, Melton III LJ. Onset and disappearance of gastrointestinal symptoms and functional gastrointestinal disorders. Am J Epidemiol 1992; 136: 165–177.
22. McColl K, Murray L, El-Omar E, Dickson A, El-Nujumi A, Wirz A, et al. Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia. N Engl J Med 1998; 26: 1869–1874.
23. Blum A, Talley NJ, O'Morain C, Veldhuyzen Van Zanten S, Labenz J, Stolte M, et al. Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. N Engl J Med 1998; 26: 1875–1881.
24. Trespi E, Broglia F, Villani L, Luinetti O, Fiocca R, Solcia E. Distinct profiles of gastritis in dyspepsia subgroups. Their different clinical responses to gastritis healing after Helicobacter pylori eradication. Scand J Gastroenterol 1994; 29: 884–888.
25. Talley NJ, Silverstein MD, Agreus L, Nyren O, Sonnenberg A, Holtmann G. AGA technical review: evaluation of dyspepsia. Gastroenterology 1997; 114: 582–595.
26. Axon A, Forman D. Helicobacter gastroduodenitis: A serious infectious disease. BMJ 1997; 314: 1430–1431.